Award
Purchase Order #75N98026P01778
Purchase Order for GEM-X Universal 5 Gene Expression by 10x Genomics
Buyer
National Institutes of Health
Award Amount
$119,915.40
Ceiling
$119,915.40
Awarded
September 25, 2026
Period of Performance
Sep 25, 2026 – Mar 31, 2027
Identifier
75N98026P01778
NAICS
621511
This award is a purchase order contract issued to 10X Genomics, Inc., a leading biotechnology company specializing in gene sequencing and genomic analysis technologies. The contract procures the GEM-X Universal 5 Gene Expression product, designed to enable advanced genetic research and analysis. This acquisition supports the National Human Genome Research Institute's efforts in genomics, contributing significantly to scientific and medical research advancements. The contract scope includes furnishing the specified gene expression product to be delivered and utilized for research purposes in Pleasanton, California. Awarded through a competitive process typical for government purchases, this multi-month agreement spans from late 2026 to early 2027. While the contract vehicle and subcontractors are not listed, the award reflects a targeted investment in cutting-edge genomic technology to further research capabilities.
Description
NHGRI - GEM-X UNIVERSAL 5 GENE EXPRESSION